John L. Green's Net Worth
$268 Thousand
Who is John L. Green?
John L. Green does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cogent Biosciences, Inc., and MERRIMACK PHARMACEUTICALS INC.
SEC CIK
John L. Green's CIK is 0001709773
Past Insider Trading and Trends
2019 was John L. Green's most active year for acquiring shares with 4 total transactions. John L. Green's most active month to acquire stocks was the month of January. 2020 was John L. Green's most active year for disposing of shares, totalling 2 transactions. John L. Green's most active month to dispose stocks was the month of June. 2022 saw John L. Green paying a total of $1,112,220.00 for 225,000 shares, this is the most they've acquired in one year. In 2021 John L. Green cashed out on 17,813 shares for a total of $157,823.18, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cogent Biosciences, Inc. (COGT) Snapshot price: $10.47
Chief Financial OfficerJohn L. Green owns 3,841 units of Common Stock which is worth $40,215.27. From 2019 to 2024 John L. Green acquired a total of 111,731 shares in Cogent Biosciences, Inc., John also disposed a total of 49,686 shares of Cogent Biosciences, Inc. equalling to $227,943.78.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
| -82.26% | -17.81K |
$8.86 | -$157,823.18 | 3.84K |
Apr 26
| |||
Form 4
| +2.48% | 524 |
—
|
—
| 21.65K |
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
∞
| 1.75K |
—
|
—
| 1.75K |
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
∞
| 77.59K |
$2.20 | -$70,120.60 | 77.59K |
Jul 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MERRIMACK PHARMACEUTICALS INC (MACK) No price found
Principal Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||